ClinConnect ClinConnect Logo
Search / Trial NCT05301049

Prevalence, Severity, Risk Factors, and Prognostic Value of Hyponatremia in Patients With Traumatic Brain Injury

Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Mar 28, 2022

Trial Information

Current as of August 02, 2025

Unknown status

Keywords

Hyponatremia Syndrome Of Inappropriate Anti Diuretic Hormone (Siadh) Cerebral Salt Waste Syndrome (Csw)

ClinConnect Summary

This is a retrospective descriptive study.

The included patients will be those admitted in the trauma intensive care unit of Lapeyronie University Hospital (Montpellier, France) with a TBI (head AIS ≥1) during a period of 4 years, 01/01/2014 to 31/12/2017.

Using our databank the investigators estimate 650 to 700 patients who met inclusion criteria during this period and will be analyzed. Inclusions will be confirmed after the opening of medical records.

Definition of SIADH is defined as the occurrence of a hyponatremia (≤135 mmol/L) associated with inappropriate urine concentration (urin...

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • âge ≥ 18 years
  • presence of traumatic brain injury at the ICU admission
  • Exclusion criteria:
  • Discharged from ICU or death \< 48 hours from the admission
  • Lack of data

About University Hospital, Montpellier

The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.

Locations

Montpellier, Montepllier, France

Patients applied

0 patients applied

Trial Officials

Jonathan CHARBIT, MD

Principal Investigator

University Hospital, Montpellier

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials